Table 3 Noncoding RNAs that regulate Wnt/β-catenin signaling pathway
From: Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy
ncRNAs | Regulated molecules | Related tumors | Ref. |
|---|---|---|---|
miR-135b | β-catenin | Ovarian cancer | [137] |
miR-388-5p | WIF1, Wnt8 | Pancreatic cancer | [138] |
miR-31 | DKK1 | Breast cancer | [139] |
miR-183 | AXIN2 | Breast cancer | [140] |
miR-374a | TCF/LEF, WIF1, PTEN, Wnt5a | Breast cancer | [141] |
miR-106a-3p | APC | Hepatocellular carcinoma | [142] |
miR-494 | APC | Colorectal cancer | [143] |
miR-106a-3p | APC | Gastric cancer | [144] |
miR-100 | APC | Colorectal cancer | [145] |
miR-125b | APC | Colorectal cancer | [145] |
miR-455-3p | GSK3β | Esophageal squamous cell carcinoma | [161] |
miR-1246 | GSK3β | Hepatocellular carcinoma | [162] |
miR-128-3p | AXIN1, SFRP2, WIF1 | Non-small cell lung cancer | [163] |
miR-410 | DKK1, DKK3 | Colorectal cancer | [147] |
miR-22-3p | β-catenin | Glioblastoma | [164] |
miR-22-5p | β-catenin | Glioblastoma | [164] |
miR-181a | STAB1 | Ovarian cancer | [165] |
miR-448 | SFRP4 | LC | [166] |
MiR-145 | SOX2 | Glioblastoma | [167] |
miR200c | DACH1 | PTC | [168] |
miR-19b | FBXW7 | Colorectal cancer | [169] |
miR-27a | FOXO1 | Ovarian cancer | [170] |
miR-128-3p | AXIN1, SFRP2, and WIF1 | Non-small cell lung cancer | [148] |
miR-182-5p | FOXO3a and β-catenin | Hepatocellular carcinoma | [149] |
miR-652 | RORA | Endometrial cancer | [150] |
miR-496 | RASSF6 | Colorectal cancer | [151] |
lncRNA-CRNDE | Wnt2, FZD4 and β-catenin | Hepatocellular carcinoma | |
lncRNA-JPX | GSK3β | LC | [171] |
lncRNA-LALR1 | AXIN | Hepatocellular carcinoma | [155] |
lncRNA-CCAL | AP-2α | Colorectal cancer | [156] |
lncRNA-NEAT1 | DDX5 | Colorectal cancer | [157] |
lncRNA-β-Catm | EZH2 | Colorectal cancer | [158] |
lncRNA-LINC01606 | TFE3 | Colon cancer | [160] |